Search results: pulmonary embolism

12 item(s) found

1 to 12 of 12
    Thrombolytic Agents
  • Alteplase

    Treating blood clots in the lungs. It is also used to improve heart function and survival following a heart attack. It is also used to improve recovery and reduce disability in cer...

    Continue reading...
  • Multikinase inhibitors
  • Axitinib

    Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3  and if one previous systemic therapy for kidney cell ...

    Continue reading...
  • EGFR Inhibitor
  • Panitumumab

    Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic a...

    Continue reading...
  • Blood Product Derivative
  • Fibrinogen

    Fibrinogen is a man-made form of a protein that occurs naturally in the body and helps the blood to clot. Fibrinogen is used to treat bleeding episodes in people with a congenital ...

    Continue reading...
  • Blood
  • Antidote
  • Anticoagulants
  • Apixaban

    Apixaban is an oral, direct, and highly selective factor Xa (FXa) inhibitor (of both free and prothrombinase-bound FXa independently of antithrombin III) for the prevention and tre...

    Continue reading...
  • Anisindione

    Anisindione is indicated for the prophylaxis and treatment of venous thrombosis and its extension, the treatment of atrial fibrillation with embolization, the prophylaxis and trea...

    Continue reading...
  • Antineoplastic Agents
  • Megestrol

    Megestrol Acetate is a synthetic, antineoplastic and progestational drug. Megestrol tablets are used to relieve the symptoms and reduce the suffering caused by advanced breast canc...

    Continue reading...
  • Entrectinib

    Entrectinib is used in adults to treat non-small cell lung cancer that has spread to other parts of the body (metastatic). Entrectinib is also used in adults and children at least...

    Continue reading...